Higher levels of GDF15 were associated with poorer survival in the combined PVOD, IPAH, and HPAH cohort (Figure 1N), with a similar trend observed in the PVOD cohort (Supplemental Figure 2C). Here, GDF15 is linked to pulmonary venoocclusive disease.